0

Peripheral Artery Disease Market Expected to Reach $10.8 Billion by 2035

 
2022
Peripheral Artery Disease Market

Report Code : A03968

quote The peripheral artery disease market is expected to register significant growth aging population and rising prevalence of diabetes and obesity, the incidence of PAD is expected to escalate globally. Furthermore, advancements in diagnostic technologies, such as non-invasive imaging modalities and biomarker identification, is anticipated to enhance early detection rates, consequently fostering market growth. Moreover, the increasing adoption of minimally invasive procedures, like angioplasty and stenting, over traditional surgical interventions has not only improved patient outcomes but also expanded the addressable patient pool. However, despite these advancements, challenges persist, including limited reimbursement policies and healthcare infrastructure disparities, particularly in emerging economies. quote

Roshan Deshmukh - Manager
Life Sciences at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, “Peripheral Artery Disease Market," The peripheral artery disease market was valued at $4.5 billion in 2023, and is estimated to reach $10.8 billion by 2035, growing at a CAGR of 7.7% from 2024 to 2035.

Peripheral arterial disease (PAD) is a common circulatory condition where narrowed arteries reduce blood flow to the limbs, typically the legs. This narrowing is usually caused by atherosclerosis, a buildup of plaque consisting of fatty deposits and cholesterol in the arterial walls. As a result, affected individuals may experience symptoms such as leg pain, cramping, numbness, weakness, or heaviness, especially during physical activity. Peripheral arterial disease is a significant risk factor for other cardiovascular problems, including heart attack and stroke.

The peripheral artery disease market size is expected to register significant growth owing to a rise in adoption of minimal invasive procedures and surge in prevalence of the peripheral artery disease. Minimally invasive procedures, such as angioplasty and atherectomy, is highly adopted by healthcare professionals and patients for treating peripheral artery disease because they involve smaller incisions, use advanced technologies like catheters and stents, and often allow for quicker patient recovery. According to 2023 article by National Library of Medicine, it was reported that balloon angioplasty or stent placement provides a minimally invasive, percutaneous treatment option for patients with peripheral artery disease symptoms that do not respond to exercise or medical therapy.

One key factor driving minimal invasive procedures adoption is the lower risk associated with minimally invasive interventions. Patients typically experience reduced trauma to surrounding tissues, less pain, and a decreased likelihood of complications compared to open surgeries. Furthermore, minimal invasive procedures are often performed on an outpatient basis or with shorter hospital stays, which can contribute to cost savings for healthcare systems. Thus, the rise in adoption of the minimal invasive procedures is expected to significantly contribute in the growth of peripheral artery disease market size.

In addition, according peripheral artery disease market analysis, rise in prevalence of peripheral artery disease is expected to drive growth of the market. According to 2023 article by American College of Cardiology, it was estimated that around 12 million Americans suffer from peripheral artery disease. Peripheral artery disease is primarily associated with aging and is exacerbated by risk factors such as diabetes, obesity, smoking, and hypertension. With an aging global population and an increase in these risk factors, the prevalence of peripheral artery disease has been steadily increasing over the years. The growing prevalence of peripheral artery disease has resulted in a higher demand for diagnostic and therapeutic interventions. As more individuals are diagnosed with prevalence of peripheral artery disease, there is a greater need for effective treatment options to manage symptoms and improve outcomes. Thus, rise in prevalence of peripheral artery disease is expected to positively impact the peripheral artery disease market growth.

The peripheral artery disease industry is segmented by product type, end user, and region. By product type the market is bifurcated into drugs and devices. By end user, the market is divided into hospitals, specialized clinics and ambulatory surgeries centers. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

Major key players that operate in the peripheral artery disease industry are Philips N.V., Braun Melsungen AG, Medtronic, Bayer AG, Boston Scientific Corporation, Becton Dickinson and Company, Terumo Medical Corporation, Biotronik, Cardinal Health, Abbott. By product type, the market is classified into drugs, and devices. The drugs segment dominated the peripheral artery disease market share in 2023 and is expected to maintain its dominance during the forecast period. This is attributed to the fact that the patient needs to take the drugs for life time once diagnosed with peripheral artery disease. On the other hand, the device in majority of the cases purchased only once in the lifetime by the patient.

By End User, the market is classified into hospital and specialized clinics. The hospital segment dominated the  peripheral artery disease market share in 2023. This is attributed the fact that treating peripheral artery disease often requires advanced medical interventions such as angioplasty, stenting, or bypass surgery. These procedures are typically performed in hospital settings where specialized equipment, operating rooms, and skilled medical personnel are readily available.

However, according to peripheral artery disease market trends analysis the specialty clinics segment is anticipated to register fastest growth during the forecast period owing to advancement in technology that have led to the development of minimally invasive procedures for treating peripheral artery disease, such as endovascular angioplasty and stenting. Specialty clinics equipped with the necessary imaging and interventional tools can perform these procedures on-site, catering to patients seeking less invasive treatment options with shorter recovery times.

On the basis of region, North America accounted for the largest share in 2023 and is expected to remain dominant during the forecast period, owing to well-established healthcare infrastructure and rise in prevalence of peripheral artery disease. However, according to peripheral artery disease market forecast analysis Asia-Pacific is anticipated to witness notable growth, owing to rise in geriatric population and unhealthy lifestyle. 

Key Findings of the Study   

  • On the basis of product type, the drugs segment dominated the peripheral artery disease market share in terms of revenue in 2023. 
  • On the basis of end user, the hospital segment dominated the market in terms of revenue in 2023. However, the specialty clinics segment is expected to register the highest CAGR during the forecast period.
  • On the basis of region, North America dominated the market in terms of revenue in 2023. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
     
 

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Peripheral Artery Disease Market by Product Type (Devices, Drugs), by End User (Hospitals, Specialty Clinics): Global Opportunity Analysis and Industry Forecast, 2024-2035 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 

Buy Full Version
"Peripheral Artery Disease Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers